Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Development of this comprehensive bispecific antibody program included policy development; toxicity management; creation of patient and staff education documents; creation of clinician tools like a toxicity scoring and charting tool and an electronic order set that segregates treatment options; and a monitoring system to safely transition patients from inpatient to outpatient care.
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Through education and advocacy projects and in partnership with programs and practices nationwide, ACCC seeks to improve access to quality cancer care for those diagnosed with melanoma.
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Your professional development is important to us! Please check back for upcoming event listings or click the button below to sign up for email updates about upcoming meetings and educational opportunities. If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact CorporateRelations@accc-cancer.org. SUBSCRIBE TO RECEIVE EMAIL UPDATES
Zaltrap-Billing-and-Coding-Guide
ASSOCIATION OF CANCER CARE CENTERS 1 BACKGROUND MCL is historically considered an incurable disease with a median progression-free survival as long as 5 years, but late relapses still occur.1 Because MCL is rare, only highly specialized providers will see large numbers of patients with relapsed or refractory (R/R) disease. This creates a challenge for providers to stay …
ICLIO National Conference ICLIO National Conference Gary I. Cohen, MD Emeritus Chair, Berman Cancer Institute, GBMC Associate Professor, Oncology, SKCCC/JHU Care Coordination: General Perspectives on I-O Therapies 9.30.16 Philadelphia, Pa. accc-iclio.org Cancer Treatment Interventions • Surgery (radical, palliative, other?) …
FAN-Top-Denial-Codes
Slide 1 Se young Han¹, Celalettin Ustun², Fiona He¹ Division of Hematology Oncology and Transplant, University of Minnesota, Minneapolis MN, USA¹ Division of Hematology Oncology and Cellular therapy, Rush University, Chicago, IL, USA² ■ Cytogenetic abnormalities at diagnosis is a crucial prognostic marker in patients with acute myeloid leukemia. ■ Cytogenetic evolution (CE) is defined …
ICLIO National Conference ICLIO National Conference Una Hopkins, DNP, FNP-BC Administrative Director Center for Cancer Care White Plains Financial Issues in Community Cancer Centers accc-iclio.org 9.30.16 Philadelphia, Pa. WPH Center for Cancer Care • 70,000 square feet Center for Cancer Care houses: Surgical Oncology, Medical …
ND08-Impact-of-Payer-Coverage-and-Reimbursement-Policies-on-Off-Label-Use-of-Anticancer-Therapies
Microsoft Word - ACCC APM Agenda for AMCCBS.docx ACCC Alternative Payment Model Coalition Workshop: Spring 2021 Friday, March 5, 2021 Workshop facilitators will walk attendees through a review of the current landscape of alternative payment models, assess experiences with both federal and commercial models, and identify needs of cancer care delivery community …